Abstract Transchromosomic (Tc) technology using human chromosome fragments (hCFs), or human artificial chromosomes (HACs), has been used for generating mice containing Mb-sized segments of the human genome. The most significant problem with freely segregating chromosomes with human centromeres has been mosaicism, possibly due to the instability of hCFs or HACs in mice. We report a system for the stable maintenance of Mb-sized human chromosomal fragments following translocation to mouse chromosome 10 (mChr.10). The approach utilizes microcell-mediated chromosome transfer and a combination of site-specific loxP insertion, telomere-directed chromosome truncation, and precise reciprocal translocation for the generation of Tc mice. Human chromosome 21 (hChr.21) was modified with a loxP site and truncated in homologous recombination-proficient chicken DT40 cells. Following transfer to mouse embryonic stem cells harboring a loxP site at the distal region of mChr.10, a *4 Mb segment of hChr.21 was translocated to the distal region of mChr.10 by transient expression of Cre recombinase. The residual hChr.21/mChr.10ter fragment was reduced by antibiotic negative selection. Tc mice harboring the translocated *4 Mb fragment were generated by chimera formation and germ line transmission. The hChr.21-derived Mb fragment was maintained stably in tissues in vivo and expression profiles of genes on hChr.21 were consistent with those seen in humans. Thus, Tc technology that Electronic supplementary material The online version of this article
Introduction
Genes that share related functions, or common elements in their regulation, are often clustered in mammalian genomes (Nelson 1999) . These clusters exhibit coordination in the regulation of linked genes and the cis-acting elements responsible for this may be distributed over hundreds of kilobases, or megabase, distances. Mice harboring large segments of human chromosomes are very important tools for generating human disease models, investigating these cis-acting elements and their role in domain-wide regulation, as well as for biomedical applications that require the introduction of human gene clusters into mice (Devoy et al. 2012) .
Yeast artificial chromosomes (YACs) and bacterial artificial chromosomes (BACs) were first utilized for the generation of mice containing large human genomic fragments. However, conventional gene transfer techniques using viruses, plasmids, BACs, and YACs, can lead to the insertion of DNA randomly into the host genome, unpredictable arrays of multicopy insertions and an associated loss of control of gene expression in transgenic mice (Palmiter and Brinster 1986; Soriano et al. 1987; Costantini et al. 1989) . To overcome this problem, homologous recombination or recombinase-mediated genomic replacement (RMGR) using recombineered BAC vectors was applied to generate mice with single copy, large human genomic fragments at a precise locus (Yang and Seed 2003; Testa et al. 2003; Wallace et al. 2007 ). Although YACs were used for the generation of these transgenomic mice, the 1-2 Mb upper limit on insert size and occasional instability in YACs limits the utility of the approach (Burke et al. 1987) .
Human chromosome fragments (hCFs) derived from normal fibroblasts have also been used as vectors for animal transgenesis, including the introduction of large, Mb-sized, genomic inserts into mice via microcell-mediated chromosome transfer (MMCT) technology (Tomizuka et al. 1997 ). Down's syndrome (DS) model mice were created by the transfer of an intact human chromosome 21 (hChr.21) into embryonic stem cells by MMCT O'Doherty et al. 2005) . Trisomy of chromosome 21 is the most common live-born human aneuploidy and results in a constellation of features known as Down's syndrome (Antonarakis et al. 2004) . These mice containing an extra hChr.21 showed cardiac abnormalities and behavioral impairment similar to patients with DS. However, germ line transmission was limited in this model, indicating that an intact hChr.21 may not serve as a good vector in Tc mice, due to the large number of human genes introduced Shinohara et al. 2000) . We therefore generated a minimal HAC vector from hChr.21 in homologous recombination-proficient chicken DT40 cells . This HAC was depleted of all endogenous genes and formed the basis of a HAC-mediated genomic transfer (HMGT) system (Kazuki et al. 2008) . However, freely segregating HACs, as well as hCFs, were not mitotically stable in proliferative mouse tissues, such as spleen and bone marrow, making further analysis of its effects on phenotypes difficult (Takiguchi et al. 2012; Shinohara et al. 2000; Shinohara et al. 2001; O'Doherty et al. 2005) .
In this study, we established a new strategy for the stable maintenance of large human genomic regions from normal hCF in mice. A combination of loxP insertion/telomere-directed chromosome truncation in DT40 cells and mouse ES cells, MMCT and Cre/loxPmediated chromosome translocation were used. We refer to this strategy as chromosome transfer-and recombinase-mediated genomic transfer (CT-RMGT). As a proof of concept, we established a stable Tc mouse harboring a *4 Mb region from hChr.21. We generated the Tc mice with the following 8 steps: (1) targeted introduction of loxP into the terminal region of mChr.10 in mouse ES cells, (2) targeted introduction of loxP into hChr.21 at the AML1 locus in DT40 cells, (3) targeted telomere associated chromosomal truncation of hChr.21 at the ETS2 locus in DT40 cells, (4) MMCT of the modified hChr.21 to the modified mouse ES line, (5) Cre-loxP mediated reciprocal chromosome translocation in mouse ES cells, (6) removal of residual hChr.21/mChr.10ter chromosome from the ES cells, (7) generation of chimeric mice and (8) breeding and germ line transmission of the Tc mice. The utility of this system was confirmed by demonstrating germ line transmission and retention of the *4 Mb region in tissues of the Tc mice. The *4 Mb fragment was maintained stably and expression profiles of genes on hChr.21 were consistent with those seen in humans.
Results
Introduction of loxP into the terminal region of mChr.10 in mouse ES cells Our strategy for generating a chromosomal translocation of the hChr.21-derived *4 Mb region to mChr.10 is summarised in Fig. 1 . Since there were no reports of imprinted genes on mChr.10, we selected mChr.10 as a human chromosomal acceptor site. First, we inserted a loxP into the terminal region of mChr.10 in mouse ES cells by homologous recombination. The targeting construct m10ter-DTneo-loxP-3 0 HPRT was electroporated Fig. 1 Summary of the generation of Tc mice with the hChr.21-derived 4 Mb region translocated to mChr.10. The strategy to generate a reciprocal translocation was a modification of that of Smith et al. (1995) . A loxP site was introduced to intron B of a human HPRT expression cassette. 5 0 and 3 0 fragments of this construct, each including the loxP site, were combined with either hygromycin-, or neomycin-resistance cassettes respectively as internal selection cassettes for gene targeting constructs. A loxP was inserted into the terminal region of mChr.10 in mouse ES cells (step 1) and into the AML1 locus on a hChr.21 in chicken DT40 cells (step 2) by homologous recombination. The modified hChr.21 was truncated at the ETS2 site on the modified hChr.21 in DT40 cells (step 3). The modified hChr.21 was transferred to CHO cells, then into the modified ES cell line by means of MMCT (step 4). Chromosome translocation was mediated by transient expression of Cre recombinase and HAT selection to detect reconstitution of the HPRT cassette (step 5). Negative selection (6-TG) against HPRT was applied to select against the residual hChr.21/mChr.10ter chromosome, resulting in ES cells containing the translocated 21q22 region and an otherwise normal karyotype (step 6). Approximately 4 Mb of hChr.21 was translocated to the distal terminal of mChr.10. These cells were suitable for the generation of chimeric mice (step 7) and germ line transmission of the translocated human chromosome fragment (step 8)
Transgenic Res (2014) 23:441-453 443 and drug-resistant mouse ES clones were selected in the presence of G418. Four of seventy clones were targeted correctly, as shown by PCR and Southern blot analyses (designated: ESm10loxP) (Fig. 2a, b) . Mouse ES cells with loxP at the terminal region of mChr.10 as a genomic fragment acceptor site were therefore generated successfully.
Modification of hChr. 21 in DT40 cells DT40 cells exhibit a high frequency of homologous recombination between exogenous DNA templates and their chromosomal counterparts (Buerstedde and Takeda 1991) . DT40 cells containing hChr.21 tagged with pSTneo were therefore used for the introduction of loxP and then telomere-directed chromosome truncation to provide a donor for translocaton of the 21q22. To delineate the *4 Mb region to be translocated onto mChr.10, a loxP site was first introduced to the AML1 locus at 21q22 and the hChr.21 was then truncated at the ETS2 locus in DT40 cells. Introduction of the loxP targeting construct h21AML-5 0 HPRTloxP-Hyg-TK resulted in the selection of 178 hygromycin-and G418-resistant clones. Of these, 71 were targeted correctly, as shown by PCR and Southern blot analyses (designated: h21loxP) (Fig. 3a, b) . FISH analyses showed that the targeting construct was integrated into the correct locus on hChr.21 in DT40 cells (Fig. 3c, d ). Telomere-associated chromosomal truncation at the ETS2 locus was then performed by the introduction of the pBS-TEL/ETS2 Puro targeting construct into DT40(h21loxP) cells. Two of 92 drugresistant clones selected in the presence of both puromycin and hygromycin were targeted correctly, as demonstrated by PCR (Supp. Fig. S1 ) (designated: h21loxPDE). FISH analyses showed that the targeting construct was integrated into the correct locus on h21loxP in DT40 cells (Fig. 3e) . These data suggest that incorporation of a loxP genomic acceptor site and site-specific truncation of hChr.21 were generated successfully by homologous recombination in DT40 cells. The modified hChr.21, termed h21loxPDE, was first transferred into Chinese hamster ovary (CHO) cells by microcell fusion, as direct transfer from DT40 to mouse ES cells is inefficient. The composition of h21loxPDE in CHO hybrid cells was confirmed by PCR using hChr.21-specific primers and FISH analysis (Fig. 3f , Supp. Fig. S1 ). FISH analysis demonstrated that the h21loxPDE was transferred into the CHO cells sucessfully, without recombination with host chromosomes. Two independent CHO hybrid clones were selected for further chromosome transfer to ES cells. Microcells prepared from donor hybrid CHO cells containing h21loxPDE were fused with mouse ES cells (ESm10loxP) and selected with hygromycin or puromycin. The drug resistant ESm10loxP clones were obtained at a frequency of 5 9 10 -6 per fused ES cell. Twelve clones were obtained from two independent experiments (designated: ESm10loxP(h21loxPDE)). The transferred h21loxPDE was characterized by PCR and FISH analyses in each line. PCR analysis with hChr.21-specific primers revealed that 5 of 12 clones contained markers equivalent to h21loxPDE donor CHO cells (Supp. Fig. S1 ). FISH analysis with human COT-1 DNA revealed that the transferred h21loxPDE was retained as an independent chromosome in the 3 clones analyzed (Fig. 5b) . with EcoRI and probed with the 3 0 homology fragment, to detect correct fragments of 7.5 kb (WT) or 9.4 kb (targeted allele). FISH analyses for DT40 (hChr.21) (c), DT40 (h21loxP) (d), DT40 (h21loxPDE) (e) and CHO (h21loxPDE) (f) are shown. Digoxigenin-labeled human COT-1 DNA (red) was used to detect the hChr.21. Biotin-labeled PGK-Hyg and PGK-Puro (green) were used to detect the modified loci in d, e, respectively. Chromosomal DNA was counterstained with DAPI. The insets show an enlarged image of the modified hChr.21 (arrow)
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To induce a reciprocal translocation between the loxP modified mChr.10 and hChr.21, a Cre expression vector was transfected into the ESm10loxP(h21-loxPDE) cells. The reciprocal translocation was designed to reconstitute a functional HPRT expression cassette. HAT selection was used to pick resultant clones (designated: ESm10loxP(h21loxPDE)Cre), which were characterized by PCR, Southern blot and FISH analyses. PCR analyses showed that the three clones exhibited a reconstituted 5 0 -and 3 0 -HPRT junction resulting from Cre/loxP site-directed recombination (Fig. 4a, b) . Southern blotting identified one clone, Cre#2, with a correct restriction fragment pattern for both the mChr.10cen/hChr.21tel and hChr.21cen/mChr.10tel translocated chromosomes (Fig. 4a, c) . FISH analyses confirmed the reciprocal translocation between the defined regions of the hChr.21 and mChr.10 ( Fig. 5a-c) . Finally, to eliminate the residual hChr.21/mChr.10ter chromosome (HPRT reconstituted allele) from the ES cells, 6-TG was added for negative selection in the ESm10-loxP(h21loxPDE)Cre#2 clone, since HAT resistant (HPRT positive) cells cannot survive by 6-TG b PCR analysis to detect reconstitution of the HPRT cassette using primers located within the HPRT intron B region, as indicated by arrowheads below the HPRT cassette a. ESm10loxP and ESm10loxP(h21loxPDE) were used as negative controls. pKO select HPRT transfected mouse ES were used as a positive control exhibiting a 350 bp band. Clones exhibiting a reconstituted HPRT cassette (ESm10loxP(h21-loxPDE)Cre) had a 400 bp band (350 ? 50 bp loxP sequence). c Southern blotting to detect the reconstituted HPRT cassette and the neo/hyg/TK allele. Correct reciprocal translocation in ESm10loxP(h21loxPDE)Cre #2 cells exhibited a 7.8 kb band (HindIII digestion/neo probe), a 3.4 kb band (EcoRV/neo probe) and a 11 kb band (HindIII/hprt probe). Additional bands of *25 kb (HindIII/neo probe) and *23 kb (EcoRV/neo probe) are thought to be hybridization to a PGK-neo vector incorporated to the hChr.21 during the generation of the original monochromosomal hybrid A9 cell line ). The *6.5 kb band (HindIII/HPRT probe) is though to be hybridization to the endogenous hprt gene selection. Nine 6-TG resistant clones were expanded and characterized by PCR and FISH analyses (designated: ESm10loxP(h21loxPDE)Cre6TG). PCR analyses showed that 8 of 9 clones harbored the desired *4 Mb region of hChr.21 (Supp. Fig. S1 ). FISH analyses showed that the residual hChr.21/mChr.10ter chromosome was eliminated from the ES cells (Fig. 5d ). These data indicated that a *4 Mb-sized chromosomal fragment could be translocated to the terminal of mCh.10 by Cre-loxP mediated recombination. A summary of the clonal analysis performed from step 1 to step 6 is described in Supplementary  Table S1 .
Retention of the translocated hChr.21 segment and expression of hChr.21 genes in mice Chimeric mice were produced from three independent ESm10loxP(h21loxPDE)Cre6TG clones, and chimeras with various degrees of coat-color chimerism were obtained successfully. Germ line transmission from one mouse exhibiting *90 % coat-color chimerism was confirmed by PCR analyses of pups (not shown). Pups containing the translocated chromosome were mated with wild-type (WT) mice for more than 10 generations and were used for expression analyses of tissues as described below. FISH analyses were undertaken to determine the frequency of cells that retained the translocated fragment in various tissues of Tc mice. FISH analyses showed that the hChr.21-derived *4 Mb region was present as a translocation on the terminal region of mChr.10 in cultured lymphocytes (Fig. 6a) . The karyotype was 40, XY, 10q? ; the additional region was derived from hChr.21. The retention rate of hChr.21 region was[89 % in every tissue examined (Fig. 6b, c) . Retention was lower in the spleen relative to other tissues, which is consistent with our previous observation of Tc mice . To determine if genes on the hChr.21 were expressed, reverse transcription-polymerase chain reaction (RT-PCR) analyses were performed on various tissues of adult Tc mice. SETD4, CBR1, DOPEY2 and CHAF1B on hChr.21 were expressed in all tissues examined, which was consistent with the expression profile in humans (Fig. 6d) .
Discussion
We have demonstrated that translocated Mb-size hCF can be maintained stably in mouse tissues and faithfully through germ line transmission. The CT-RMGT system we developed created a mouse strain with a human:mouse hybrid chromosome. The endogenous mouse centromere activity provided for stable maintenance of a translocated hCF containing only a targeted region of interest. This approach combines the technologies of targeted modification of human loci in DT40 and mouse loci in mouse ES cells, microcell-mediated chromosome transfer and Cre/ loxP-mediated chromosome translocation. Cre/loxPmediated chromosome translocation has previously been used successfully in mouse ES cells to generate a reciprocal translocation between mChr.12 and mChr.15 (Smith et al. 1995) , as well as chromosomal deletions/duplications and rearrangements (Olson et al. 2004 ). The efficiency of interchromosomal reciprocal translocation in this study was similar to that reported by Smith et al. (1995) .
We used a shuttle system of modification of hCF in DT40 cells, followed by sequential transfer to CHO cells and mouse ES cells (Kuroiwa et al. 2000) . Recent improvements enabling genome editing with sitespecific nucleases such as Zinc-finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs) and clustered regulatory interspaced short palindromic repeat (CRISPR)/Cas-based RNA-guided DNA endonucleases (Gaj et al. 2013) , may simplify our approaches. If these technologies support the modification of hCFs in CHO or A9 cells, we may be able to modify and transfer hCFs from libraries in these cell lines directly to mouse ES cells for the generation of Tc mice.
The Tc mice we generated had a heterozygous deletion of the terminal region of mChr.10, as the residual hCF/mChr.10ter chromosome was eliminated from the final modified ES cells. Phenotypic and behavioural testing of these Tc mice will therefore formally require a control strain with a matched heterozygous deletion of mChr.10 for comparison. This can be achieved by directed telomere truncation in mouse ES cells, using the same terminal loci targeted in this study.
A long term goal remains to create a Down's syndrome Tc model mouse with trisomy of the hChr.21 Down's syndrome critical region (DSCR) or related regions. However, the generation of Tc mice with additonal copies of this or other defined segments of hChr.21, to achieve trisomy of hChr.21 regions, may be technically challenging. The large number of loci introducted with transchromosomal appraoches may interfere with normal development. Nonetheless, with the CT-RMGT system it is theoretically possible to produce Tc mice with multiple hCFs, within the constraint of the applicable recombination systems and range of selectable markers.
Another application of CT-RMGT is the generation of animal models of human aneuploidy syndromes, which are caused by extra dosage of WT genes on human chromosomes. Although two groups have successfully generated Tc Down's syndrome model mice, the introduced hChr.21 was not mitotically stable in proliferative tissues such as the spleen and bone marrow, making further analysis of its effects on phenotypes difficult O'Doherty et al. 2005) . In this study, we translocated the *4 Mb region of hChr.21 and demonstrated that it was maintained at very high frequencies. This mouse strain will be a useful model for identifying and mapping of genes within the region that contribute to the DS phenotype. We can further apply this system by generating translocated Tc mice with different regions of hChr.21, including larger, smaller, or combinations of fragments related to DS phenotypes. These mouse models will be powerful tools for the study of phenotype-genotype correlations in DS. Finally, copy number variations (CNVs) are important forms of genetic variation in the human population, causing phenotypic traits or diseases such as autism (Nakatani et al. 2009 ). The CT-RMGT system will also be a useful tool for the generation of Tc models of human CNVs.
Previously, we have shown that a mouse artificial chromosome (MAC) vector developed by chromosome engineering is more stable in adult tissues and hematopoietic cells in mice than are HAC vectors (Takiguchi et al. 2012) . Similarly, the hChr.21 fragment that we translocated to mChr.10 was stable under the control of the mouse centromere in multiple tissues in this study. Therfore, MACs hosting translocated hCFs may be a useful addition to this CT-RMGT system. MACs containing large segments of human chromosomes have yet to be reported.
The CT-RMGT approach, as well as hCFs-mediated genomic transfer and HMGT, are very useful technologies for the introduction of Mb-sized human chromosomal regions into mice. However, more accurate humanization may possibly be achieved if endogenous homologous regions of the mouse genome are also deleted. RMGR enables the replacement of segments of the mouse genome with syntenic regions of the human genome by the modification of human BAC and homologous recombination in mouse ES cells (Wallace et al. 2007 ). However, the upper limit of the approach is *300 kb, the maximal cloning capacity of BAC vectors (Shizuya et al. 1992) . CT-RMGT may enable larger scale replacement, via the introduction of heterotypic lox sites in DT40 cells. Humanized mouse strains containing the full set of immunoglobulin genes, or the drug metabolizing CYP3A enzyme genes have been generated using a combination of gene knockout of endogenous loci and transfer of hCFs and HACs Kazuki et al. 2013 ). The CT-RMGT system will also be useful for generating similar strains of humanized mice.
Taken together, the CT-RMGT system developed in this study could enable the stable maintenance of hCFs in mouse tissues and efficient passage through the germ line. This represents a sophisticated system for the development of the next generation of transchromosomic mice. This integrated system includes targeted modification of human and mouse loci, chromosome transfer, translocation, chimera formation and stable germ line transmission. CT-RMGT could therefore enable the development of Tc mice carrying stable hCFs for human disease models and investigation of human genomic functions.
Materials and methods

Plasmids and vectors
mChr.10 loxP vector: The targeting vector contained homology arms from the terminal region of mChr.10. A PCR based probe, D10Hgu1 (MGI database, Jackson Laboratories), was used to screen a P1 genomic library, from which a 12.4 kb PstI fragment was identified within a genomic clone, subcloned, restriction mapped and used to construct the m10ter-DTneo-loxP-3 0 HPRT vector. The targeting vector consisted of a 1.2 kb RsrII diphtheria toxin negative selection cassette from pKO Select DT V840 (Lexington Genetics), a 6.5 kb EcoRI 5 0 homology fragment, a PGK-neomycin resistance expression cassette, a loxP site, exons 3-9 of human HPRT from pKO Select HPRT V820 (Lexington Genetics) and a 3.7 kb EcoRI 3 0 homology fragment, in the 1.9 kb pKO Scrambler V913 vector backbone (Lexicon Genetics). hChr.21 loxP vector: The targeting vector contained homology arms from the AML1 locus (hChr.21q22), which were amplified by PCR using primers AML5 0 L1/AML5 0 R2 (2.9 kb); AML3 0 L4/AML3 0 R4 (2.0 kb) (Suppl Table S2 ). The targeting vector h21AML-5 0 HPRT-loxP-Hyg-TK consisted of a 2.9 kb AML 5 0 homology fragment, PGK-exons 1-2 human HPRT from pKO Select HPRT V820 (Lexington Genetics), a loxP site, a PGK-hygromycin expression cassette, a HSV-thymidine kinase expression cassette and a 2 kb AML 3 0 homology fragment, in the 1.9 kb pKO Scrambler V901 vector backbone (Lexicon Genetics). ETS2 telomere truncation vector: The pBS-TEL/ETS2 Puro targeting construct used in this study has been described previously (Kazuki et al. 2004 ).
Cell culture
Chicken DT40 cells containing hChr.21 were generated previously (Kazuki et al. 2004 ) and maintained at 40°C in RPMI 1640 medium supplemented with 10 % fetal bovine serum (FBS), 1 % chicken serum, 50 lM 2-mercaptoethanol and 1.5 mg/ml G418. CHO-K1 cells used as fusion recipients for chromosome transfer were maintained at 37°C in Ham's F-12 nutrient mixture (Life Technologies, Carlsbad, CA, USA) supplemented with 10 % bovine calf serum. Mouse embryonic fibroblasts (MEFs) were isolated from 13.5 days post-coitum (d.p.c.) embryos. MEFs were grown in Dulbecco's modified Eagle's medium (DMEM) (Sigma, St Louis, MO, USA) with 10 % FBS. The parental mouse ES cell lines, hprt-deficient TT2F and E14tg2a, and the microcell hybrid clones, were maintained on mitomycin C (Sigma)-treated Jcl:ICR (CLEA Japan, Tokyo, Japan) MEFs as a feeder layers in DMEM with 18 % FBS (Hyclone), 1 mM sodium pyruvate (Life Technologies), 0.1 mM non-essential amino acids (Life Technologies), 0.1 mM 2-mercaptoethanol (Sigma), 2 mM L-glutamine (Life Technologies), and 1,000 U/ml leukemia inhibitory factor (LIF) (Funakoshi, Tokyo, Japan).
Modification of hChr.21 in DT40 cells
Homologous recombination-proficient chicken DT40 cells (1 9 10 7 ) were collected in 0.5 mL RPMI with 25 lg of linearized targeting vector and electroporated at 550 V and 25 lF using a Gene Pulser apparatus (Bio-Rad, Hercules, CA, USA). Drug-resistant DT40 (h21loxP) and DT40 (h21loxPDE) clones were selected in 1.5 mg/mL G418 and 1.5 mg/mL hygromycin, and in 1.5 mg/mL hygromycin and 0.3 lg/mL puromycin, respectively. Homologous recombination in DT40 hybrid clones was identified by PCR and confirmed by Southern blotting as follows.
Modification of mChr.10 and translocation of mChr.10-hChr.21 in mouse ES cells For insertion of loxP into the terminal region of mChr.10 by homologous recombination, 2.5 9 10 7 mouse ES cells were resuspended in HBS, mixed with 50 lg of linearized m10ter-DTneo-loxP-3 0 HPRT and electroporated at 960 lF and 250 volts in a Bio-Rad Gene Pulser. The cells were then incubated for 48 h without selection, before clonal selection in 250 lg/ml G418. Colonies were picked after 7-10 days and expanded for PCR and Southern blot analyses. For Cre-loxP mediated chromosome translocation, 3 9 10 mouse ES cells were resuspended in HBS, mixed with 100 lg of the pBS185 Cre expression vector (Life Technologies), and electroporated at 3 lF and 800 volts in a Bio-Rad Gene Pulser. The cells were then incubated for 48 h without selection, before clonal selection in 1 9 HAT (Sigma). Colonies were picked after 10-13 days and expanded for PCR, Southern blot and FISH analyses. For selection against the residual hChr.21/mChr.10ter, 1 9 10 7 mouse ES cells were selected in 0.5 lg/ml 6-TG.
MMCT
Microcell-mediated chromosome transfer was performed as described previously (Tomizuka et al. 1997 ). DT40 cells containing the h21loxPDE were transferred to CHO cells by MMCT. CHO cells containing the h21loxPDE were used as donors for microcell hybrids. Briefly, mouse ES cells were fused with microcells prepared from CHO (h21loxPDE) donor cells, and selected with puromycin (0.6 lg/mL) or hygromycin (200 lg/mL). The transferred h21loxPDE in each line was characterized by PCR and fluorescence in situ hybridization (FISH) analyses as follows.
Genomic PCR analyses
Genomic DNA was extracted from cell lines and Tc mouse tissue specimens using a genomic extraction kit (Gentra System, Minneapolis, MN, USA). PCR to detect regions of hChr.21 was performed with the primers listed in Supplementary Table S2 . The primer pairs for detecting the targeting of m10ter-DTneo-loxP-3 0 HPRT at the mChr.10 terminal (4B.L1/4A.R2), the Cre-loxP-mediated chromosomal translocation between the mChr.10 and modified hChr.21 (TRANS L1/TRANSR1) and chromosome truncation at the ETS2 locus (ETS2-L/Puro1) are also described in Supplementary Table S2 . DT40, CHO-K1, TT2F and normal mouse tissues were used as negative controls.
Southern blot analyses
Southern blotting was used to confirm homologous recombination in DT40 cells and mouse ES cells and to detect chromosome translocation in mouse ES cells. Digested DNA samples were separated on a 0.8 % agarose gel by electrophoresis and transferred to a Hybond N? membrane (Amersham, Buckinghamshire, UK) in an alkaline solution. Probes were labelled with 32 P-dCTP by Klenow polymerase and hybridized to the filters overnight in 5 9 SSPE, 0.5 % SDS, 100 lg/ml salmon sperm DNA at 65°C. Filters were washed in 2 9 SSC, 0.1 % SDS at room temperature for 5 min; twice in 2 9 SSC, 0.1 % SDS at 60°C for 30 min and once in 0.2 9 SSC, 0.1 % SDS at 60°C for 10 min. Filters were exposed to a Fuji systems BAS phosphorimager, or were visualized by scientific imaging film (Kodak, Tokyo, Japan). Primer pairs used for generating probes were: 13R-R/13R-L (m10loxP clones), SP4L/SP4R (5 0 probe in h21loxP clones), SP7L/SP7R (3 0 probe in h21loxP clones). Primer sequences are indicated in Supplementary Table S2 . A 630 bp fragment (neo probe), isolated by PstI/XbaI digestion of pGK neo bpA, and a 320 bp fragment (hprt probe) derived from the exon 3-9 sequence of the HPRT cassette, isolated by XhoI/HindIII digestion of pKO SelectHPRT, were used for the confirmation of the chromosomal translocation.
FISH analyses
Tissue samples were homogenized and incubated for 15 min in 0.075 M KCl, fixed with methanol and acetic acid (3:1), and then slides were prepared using standard methods. FISH analyses were performed using fixed metaphase or interphase spreads of each cell hybrid or cultured lymphocytes using digoxigenin-labeled (Roche, Basel, Switzerland) human COT-1 DNA (Life Technologies) and biotin-labeled DNA (PGK-Puro and PGK-Hygro), essentially as described previously (Tomizuka et al. 1997) . Chromosomal DNA was counterstained with DAPI (Sigma-Aldrich). Images were captured using an AxioImagerZ2 fluorescence microscope (Carl Zeiss GmbH), the NIS-elements system (Nikon, Tokyo, Japan), or the Argus system (Hamamatsu Photonics, Shizuoka, Japan).
Generation of chimeric mice and Tc mice
Tc chimeric mice were produced from the three ESm10loxP(h21loxPDE)Cre6TG clones, with chimera production completed as described previously (Tomizuka et al. 1997) . Briefly, ES cells were injected into eight-cell-stage embryos derived from ICR mice (CLEA, Tokyo, Japan) and then transferred into pseudo-pregnant ICR females. Between seven and ten chimeric mice, each showing 70-100 % coat-color chimerism, were mated with ICR mice for generation of germ line-transmittable mice. Between three and five mice were used for genomic PCR, RT-PCR and FISH analyses. Representative data are shown in each figure. All animal experiments were approved by the Animal Care and Use Committee of Tottori University.
RT-PCR analyses
Total RNA from Tc tissue specimens was prepared using ISOGEN (Nippon Gene, Tokyo, Japan) and purified using RNeasy columns (Qiagen, Hilden, Germany), in accordance with the manufacturer's instructions, and were then treated with RNase-free DNase I (Wako Pure Chemicals, Osaka, Japan). Firststrand cDNA syntheses was performed using random hexamers and SuperScript III reverse transcriptase (Life Technologies). Primer sequences for detection of the expression of hChr.21 genes and mouse/human Gapdh were described in Supplementary Table S2 . Gapdh was used as an internal control. cDNA from human tissues (Takara Bio, Shiga, Japan) was used as a positive control, while cDNA from ICR mouse tissues was used as a negative control. PCR was performed using ExTaq (Takara Bio, Shiga, Japan) or AmpliTaq Gold (Perkin Elmer, Waltham, MA, USA). Amplifications used annealing temperature's of 56-62°C for 25-35 cycles. Amplified fragments were resolved by electrophoresis on 2 % agarose gels, followed by staining with ethidium bromide.
